{"DataElement":{"publicId":"6922533","version":"1","preferredName":"Overall Lesion Response irRC Measurable Category","preferredDefinition":"A set of response criteria designed to capture additional response patterns observed with immune therapy beyond those described by Response Evaluation Criteria in Solid Tumors (RECIST) or WHO criteria.","longName":"RSOVRRSP","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6922065","version":"1","preferredName":"Disease Response Domain Overall Disease Response Assessment Test","preferredDefinition":"A domain for disease response evaluations._Including everything._A character or string that represents the long name of the disease response assessment.","longName":"6608777v1.0:6922063v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6922063","version":"1","preferredName":"Overall Disease Response Assessment Test","preferredDefinition":"Including everything.:A character or string that represents the long name of the disease response assessment.","longName":"C25605:C117404","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Overall","conceptCode":"C25605","definition":"Including everything.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response Assessment Test","conceptCode":"C117404","definition":"A character or string that represents the long name of the disease response assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"92380E2F-2B15-4CD6-E053-F662850A5FE6","latestVersionIndicator":"Yes","beginDate":"2019-09-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-10","modifiedBy":"ONEDATA","dateModified":"2019-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"92380E2F-2B26-4CD6-E053-F662850A5FE6","latestVersionIndicator":"Yes","beginDate":"2019-09-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-10","modifiedBy":"KUMMEROA","dateModified":"2020-06-18","changeDescription":"Released. AK 2020-6-10; Created for CDSIC aligned NCI Standard CRFs. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6161683","version":"1","preferredName":"irRC Measurable Overall Response Category","preferredDefinition":"A set of response criteria designed to capture additional response patterns observed with immune therapy beyond those described by Response Evaluation Criteria in Solid Tumors (RECIST) or WHO criteria._Capable of being measured._An assessment of the overall response of the disease to the therapy._A grouping of items based on some commonality or by user defined characteristics.","longName":"6161683v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"irCR","valueDescription":"irCR (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161693","version":"1","preferredName":"irCR (Immune-Related Response Criteria)","longName":"6161693","preferredDefinition":"Complete disappearance of all lesions (whether measurable or not, and no new lesions); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Complete Response","conceptCode":"C148193","definition":"Complete disappearance of all lesions (whether measurable or not, and no new lesions); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0B50-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F4496-0B68-378D-E053-F662850AA125","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"irPD","valueDescription":"irPD (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161694","version":"1","preferredName":"irPD (Immune-Related Response Criteria)","longName":"6161694","preferredDefinition":"Increase in tumor burden greater than or equal to 25 percent relative to nadir (minimum recorded tumor burden); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Progressive Disease","conceptCode":"C148196","definition":"Increase in tumor burden greater than or equal to 25 percent relative to nadir (minimum recorded tumor burden); confirmation by a repeat, consecutive assessment no less than 4 weeks from the date first documented.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0B75-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F4496-0B8D-378D-E053-F662850AA125","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"irPR","valueDescription":"irPR (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161695","version":"1","preferredName":"irPR (Immune-Related Response Criteria)","longName":"6161695","preferredDefinition":"Decrease in tumor burden greater than or equal to 50 percent relative to baseline confirmed by a consecutive assessment at least 4 weeks after first documentation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Partial Response","conceptCode":"C148194","definition":"Decrease in tumor burden greater than or equal to 50 percent relative to baseline confirmed by a consecutive assessment at least 4 weeks after first documentation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0B9A-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F4496-0BB2-378D-E053-F662850AA125","beginDate":"2018-04-02","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"},{"value":"irSD","valueDescription":"irSD (Immune-Related Response Criteria)","ValueMeaning":{"publicId":"6161696","version":"1","preferredName":"irSD (Immune-Related Response Criteria)","longName":"6161696","preferredDefinition":"Not meeting criteria for irCR or irPR, in absence of irPD.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria Stable Disease","conceptCode":"C148195","definition":"Not meeting criteria for irCR or irPR, in absence of irPD.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691F4496-0BBF-378D-E053-F662850AA125","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"691F4496-0BD8-378D-E053-F662850AA125","beginDate":"2017-10-12","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6161682","version":"1","preferredName":"Immune-Related Response Criteria Measurable Overall Response Category","preferredDefinition":"A set of response criteria designed to capture additional response patterns observed with immune therapy beyond those described by Response Evaluation Criteria in Solid Tumors (RECIST) or WHO criteria.:Capable of being measured.:An assessment of the overall response of the disease to the therapy.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C148192:C37894:C96613:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Related Response Criteria","conceptCode":"C148192","definition":"A set of response criteria designed to capture additional response patterns observed with immune therapy beyond those described by Response Evaluation Criteria in Solid Tumors (RECIST) or WHO criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Measurable","conceptCode":"C37894","definition":"Capable of being measured.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Overall Response","conceptCode":"C96613","definition":"An assessment of the overall response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"691BD3EB-0213-3970-E053-F662850A163C","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"ONEDATA","dateModified":"2018-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"irRC: Immune-Related Response Criteria-2009","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"691BD3EB-0224-3970-E053-F662850A163C","latestVersionIndicator":"Yes","beginDate":"2018-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-04-05","modifiedBy":"KNABLEJ","dateModified":"2018-10-23","changeDescription":"10/23/18 jk chg reg status to Standard for RECIST defined PV list; do not add PVs without checking latest version of guideline.  4/5/18 jk created for DCI study and immune RECIST FG activities.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318366","version":"1","longName":"Response - CDISC Aligned","context":"NCI Standards"},{"publicId":"6921972","version":"1","longName":"RECIST - CDISC Aligned ","context":"NCI Standards"},{"publicId":"6921973","version":"1","longName":"irRC - CDISC Aligned","context":"NCI Standards"}]},{"publicId":"7434158","version":"1","longName":"CTEP CDISC Harmonization","context":"CTEP","ClassificationSchemeItems":[{"publicId":"7590138","version":"1","longName":"CTEP CDISC Response","context":"CTEP"},{"publicId":"7590130","version":"1","longName":"CTEP CDISC irRC","context":"CTEP"}]}],"AlternateNames":[{"name":"RS_RSORRES_OVRLRESP_IRRC","type":"CTEP CDISC CDE","context":"CTEP"}],"ReferenceDocuments":[{"name":"Overall response","type":"Preferred Question Text","description":"Overall response","url":null,"context":"NCI Standards"},{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 3553272 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"CDISC Aligned NCI Standard Equivalent CDE Question Text","type":"Alternate Question Text","description":"irRC response","url":null,"context":"NCI Standards"},{"name":"CTEP Text 1","type":"Alternate Question Text","description":"What was the irRC overall response?","url":null,"context":"CTEP"},{"name":"CTEP Text 2","type":"Alternate Question Text","description":"irRC overall response","url":null,"context":"CTEP"},{"name":"CTEP Text 3","type":"Alternate Question Text","description":"What was the overall response?","url":null,"context":"CTEP"},{"name":"CTEP Text 4","type":"Alternate Question Text","description":"Overall response","url":null,"context":"CTEP"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"92498752-EC6F-0D63-E053-F662850A6E8F","latestVersionIndicator":"Yes","beginDate":"2019-09-11","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-09-11","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Released. AK 2020-6-17; Created for CDISC aligned NCI Standard CRF task. mc","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}